Related Experiment Video
Updated: Jun 2, 2026
06:56
Development and Application of Rapamycin-regulated Tyrosine Phosphatases
Published on: September 6, 2024
Relieving autophagy and 4EBP1 from rapamycin resistance
Beat Nyfeler1, Philip Bergman, Ellen Triantafellow
1Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge,Massachusetts 02139, USA.
Molecular and Cellular Biology
|May 18, 2011
Summary
Rapamycin partially inhibits mTORC1, affecting cell growth and metabolism. Combining rapamycin with other inhibitors can achieve complete mTORC1 inhibition, offering a new therapeutic strategy.
Area of Science:
- Cellular signaling
- Molecular biology
- Cancer research
Background:
- Mammalian target of rapamycin complex 1 (mTORC1) regulates cell growth, proliferation, and metabolism.
- mTORC1 signaling is modulated by oncogenes and tumor suppressors.
- Rapamycin is an allosteric inhibitor of mTORC1 with variable effects on its downstream outputs.
Purpose of the Study:
- To investigate the reasons behind rapamycin's unequal antagonism of mTORC1 outputs.
- To explore the correlation between mTORC1 stability and rapamycin's efficacy in activating autophagy.
- To identify strategies for achieving complete and selective mTORC1 inhibition.
Main Methods:
- Analysis of mTORC1 stability in different cell lines upon rapamycin exposure.
- Use of small interfering RNA (siRNA) to knockdown raptor.
- Combination therapy using rapamycin and an ATP-competitive mTOR inhibitor.
Main Results:
- Rapamycin exposure destabilizes mTORC1, with higher mTOR-bound raptor levels in rapamycin-insensitive cells.
- Raptor knockdown by siRNA sensitizes autophagy and the eIF4E pathway to rapamycin.
- Combination therapy synergistically inhibits mTORC1 and activates autophagy while preserving mTORC2 signaling.
Conclusions:
- mTORC1 stability influences rapamycin's efficacy in modulating downstream pathways.
- Raptor plays a critical role in rapamycin resistance.
- Combination strategies involving rapamycin and ATP-competitive inhibitors offer a promising approach for complete and selective mTORC1 inhibition.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:37The Unfolded Protein Response
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
01:27Autophagy
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
01:31Regulation of the Unfolded Protein Response
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
01:22Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...